Bassukas I, Schlereth W, Deubel W, Krug R
Int J Oncol. 1995 Mar;6(3):725-9. doi: 10.3892/ijo.6.3.725.
The effect of a three-week treatment regimen with suramin (30, 60 or 90 mg/kg body weight) on the cell proliferation of small intestinal crypts and dorsal epidermis of the nude mouse was studied using standard auto-radiographic methods after in vivo pulse labeling with H-3-thymidine. Suramin was slightly toxic to the animals in a dose-dependent manner (p<0.01) as measured by the decrease of the rate of weight gain of the treated animals. In the small intestine suramin treatment led to crypt shrinkage (factor: about 70-80%; p<0.05) mainly by increasing the rate of cell loss out of the crypt epithelium (p<0.05) and to a lesser degree by inhibiting the proliferation of crypt cells. However, this suramin treatment scheme did not significantly affect the H-3-thymidine labeling index and the mitotic index of the basal cell layer of the epidermis. The present findings indicate that suramin can be used to approach the problem of differential homeostatic reactions of epithelial tissue renewal in vivo.
在用H-3-胸腺嘧啶核苷进行体内脉冲标记后,使用标准放射自显影方法研究了苏拉明(30、60或90mg/kg体重)三周治疗方案对裸鼠小肠隐窝和背部表皮细胞增殖的影响。通过处理动物体重增加速率的降低来衡量,苏拉明对动物有轻微的剂量依赖性毒性(p<0.01)。在小肠中,苏拉明治疗导致隐窝萎缩(系数:约70-80%;p<0.05),主要是通过增加隐窝上皮细胞的丢失率(p<0.05),在较小程度上是通过抑制隐窝细胞的增殖。然而,这种苏拉明治疗方案对表皮基底细胞层的H-3-胸腺嘧啶核苷标记指数和有丝分裂指数没有显著影响。目前的研究结果表明,苏拉明可用于探讨体内上皮组织更新的不同稳态反应问题。